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ABSTRACT
Objective To determine whether adding web- based 
support (e- coachER) to an exercise referral scheme (ERS) 
increases objectively assessed physical activity (PA).
Design Multicentre trial with participants randomised 
to usual ERS alone (control) or usual ERS plus e- coachER 
(intervention).
Setting Primary care and ERS in three UK sites from 
2015 to 2018.
Participants 450 inactive ERS referees with chronic 
health conditions.
Interventions Participants received a pedometer, PA 
recording sheets and a user guide for the web- based 
support. e- coachER interactively encouraged the use of 
the ERS and other PA options.
Main outcome measures Primary and key secondary 
outcomes were: objective moderate- to- vigorous PA 
(MVPA) minutes (in ≥10 min bouts and without bouts), 
respectively, after 12 months. Secondary outcomes 
were: other accelerometer- derived and self- reported PA 
measures, ERS attendance, EQ- 5D- 5L, Hospital Anxiety 
and Depression Scale and beliefs about PA. All outcomes 
were collected at baseline, 4 and 12 months. Primary 
analysis was an intention to treat comparison between 
intervention and control arms at 12- month follow- up.
Results There was no significant effect of the 
intervention on weekly MVPA at 12 months between 
the groups recorded in ≥10 min bouts (mean difference 
11.8 min of MVPA, 95% CI: −2.1 to 26.0; p=0.10) or 
without bouts (mean difference 13.7 min of MVPA, 
95% CI: −26.8 to 54.2; p=0.51) for 232 participants 
with usable data. There was no difference in the primary 
or secondary PA outcomes at 4 or 12 months.
Conclusion Augmenting ERS referrals with web- based 
behavioural support had only a weak, non- significant 
effect on MVPA.
Trial registration number ISRCTN15644451.
INTRODUCTION
Low levels of physical activity (PA) are a significant 
contributor to a wide range of chronic physical 
and mental health conditions such as obesity, type 
2 diabetes, hypertension, osteoarthritis and depres-
sion1–6 and associated healthcare cost.7 Primary care 
exercise referral schemes (ERSs) have small positive 
effects on self- reported PA, compared with usual care. 
However, most of these trials are underpowered, 
and do not necessarily include physically inactive 
participants with chronic conditions.8 9 The format 
of ERS range from considerable exercise practitioner 
contact at an exercise facility to a signposting service 
to community PA options with minimal sustained 
contact.10 This variation in ERS makes a broader 
national approach to improving the quality of the 
patient experience and effectiveness challenging. 
Given that only 66%–81% ever attend the referral 
scheme, that only 43%–49% complete it11 and that 
the health benefits seem to be small,12 new ways are 
needed to improve uptake and adherence to ERS, and 
to foster sustainable PA from ERS.13
Web- based interventions have been shown to 
be effective in supporting short- term changes 
in (mostly self- reported) PA among the general 
population and those with clinical conditions.14–18 
However, no studies have explored their use along-
side ERS offering face- to- face support. Along with 
service users, we developed a bespoke support 
system called e- coachER, using the LifeGuide plat-
form (https://www. lifeguideonline. org/), seeking 
to empower ERS participants with physical and 
mental health conditions to become more physi-
cally active and to remain motivated to do so. If 
shown to be an effective adjunctive intervention, 
such a system could be scaled up relatively cheaply 
and routinely offered to thousands of patients per 
year in hundreds of schemes in the UK.10
We undertook a multicentre parallel two- group 
randomised controlled trial to determine the impact 
of the addition of web- based behavioural support 
for ERS referral on PA and health outcomes in inac-
tive people with chronic disease.
METHODS
The trial was conducted and reported in accordance 
with the Consolidated Standards of Reporting Trials 
guidelines.19 Our full trial protocol has been published 
elsewhere so we limit the details provided here.20
Study population
Between July 2015 to March 2017, we recruited 
low active adults with at least one chronic condi-
tion (from obesity, hypertension, type 2 diabetes, 
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Glasgow, Birmingham or Plymouth and adjacent rural areas, 
who had been or were about to be referred by a primary care 
practitioner to a local ERS. For a full list of inclusion/exclusion 
criteria see online supplemental material (online supplemental 
appendix 1). For a full list of ways in which participants were 
recruited see online supplemental material (online supplemental 
appendix 2).
Study procedures
A summary of the recruitment procedures is shown in a flow 
chart in online supplemental material appendix 3, and full 
procedures were previously reported.20
Randomisation and blinding
Participants were randomly allocated 1:1 to either usual ERS 
alone (control arm) or usual ERS plus e- coachER (intervention 
arm). Randomisation was stratified by site with minimisation 
by the participant’s perceived main reason for their referral to 
the ERS (ie, chronic condition) and by self- reported IT literacy/
confidence using a 10- point scale.
Blinding to trial allocation among the trial statistician and most 
of the research team (excepting those involved in the qualitative 
process evaluation) was not broken until the primary and secondary 
analyses were reported to the Project Management Group.
Intervention
Participants allocated to the intervention group were mailed a 
small box containing a user guide for accessing the e- coachER 
web- based support system, a pedometer (step- counter) and a 
fridge magnet with tear- off sheets to record weekly step counts 
or minutes of moderate- to- vigorous PA (MVPA). The user guide 
provided a summary of the content on the website and guidance 
on how to register to access a range of interactive opportuni-
ties to enhance participants’ motivation to take up the ERS and 
to become more physically active, whether or not they engaged 
with their local ERS. A logic model for the intervention and a 
more detailed description of the content, in compliance with the 
TiDIER checklist and Behaviour Change Techniques mapping 
has been reported elsewhere.20
The interactive e- coachER support system adopted effective 
features from other interventions.21 It involved seven ‘Steps to 
Health’ designed to take about 5–10 min each to complete each 
week. We defined getting to step 5 (setting a goal and reviewing 
a goal online) as a sufficient ‘dose’ of the intervention to impact 
on minutes of MVPA, although we recognise that merely mailing 
a pedometer could, for some, be an effective intervention.22
Control
Participants in both arms of the trial were offered usual primary 
care ERS, across three different schemes, as described else-
where,20 to increase the generalisability of the trial.
Data collection
At 4 and 12 months post randomisation, participants were sent 
an accelerometer and questionnaire booklet by post, and prepaid 
envelope to return to Peninsula Clinical Trials Unit. Reminder 
letters and phone calls aimed to increase follow- up rates. Partic-
ipants returning the device received an online/high street store 
voucher for £20 on each occasion.
Outcomes measures
The primary outcome was the number of weekly minutes of 
MVPA, recorded in ≥10 min bouts, measured objectively by 
GENEActiv Original accelerometer (Activinsights; https://www. 
geneactiv. org/), over a 1- week period at 12 months post randomi-
sation. A description of our procedures for processing accelerom-
eter data is provided in online supplementary material appendix 4. 
Briefly, GENEActiv PC software (V.3.0_09.02.2015) was used with 
software R using package GGIR V.1.2-8 (https:// cran. r- project. org/ 
web/ packages/ GGIR/ index. html)23 to identify data for the primary 
analysis if participants achieved a minimum of 16 hours of wear 
time for a minimum of 4 days (including at least 1 weekend day).
Other accelerometer recorded and self- reported secondary 
outcomes at 4 and 12 months are shown in online supplemental 
material appendix 5 and table 1. Initial attendance at the ERS 
was captured from ERS providers with imputed participant- 
reported attendance at 4 weeks and/or 4 months where the 
ERS service data were missing. Engagement with the e- coachER 
intervention was captured using the LifeGuide platform. Other 
methods and data used for our health economic evaluation and 
process evaluation are reported elsewhere.20
Statistical analysis
In the absence of a published minimally important difference for 
MVPA, we assumed a ‘small- to- moderate’ standardised effect size 
of 0.35, and estimated that 413 participants were required at 88% 
power and a two- sided alpha of 5% assuming for 20% attrition, 
or 90% power at a two- sided alpha of 5% allowing for 16% 
attrition (using ‘sampsi’ in STATA V.14.2). Based on the baseline 
SD for MVPA total weekly minutes in ≥10 min bouts of 104 to 
113,24 an effect size of 0.35 would correspond to a mean between 
group differences of 36–39 min of MVPA per week at 12- month 
follow- up.
All statistical analyses were conducted to a predefined anal-
ysis plan prior to end of data collection and any comparison of 
follow- up outcomes. The primary analysis compared primary 
and secondary outcomes between groups in accordance with the 
principle of intention to treat (ITT) (ie, based on original random 
allocation) in participants with complete outcomes at 12 months, 
adjusting for baseline outcome values and stratification and mini-
misation variables. Following assessment of baseline demographics, 
mean age and gender were also added to the adjusted model.
Two secondary analyses were undertaken to compare groups 
across all follow- up points using a mixed model repeated 
measures approach and complier average causal effect (CACE) 
analyses undertaken to examine the impact of adherence to the 
intervention, (ie, (a) simply registering to access the website or 
not and (b) completing five or more ‘Steps to Health’ or not) on 
primary and secondary outcomes at 12 months.
The primary analysis model was extended to fit interaction terms 
to explore possible subgroup differences in intervention effect in 
stratification and minimisation variables for the primary outcome 
at 12 months. Given the low power for testing interactions, these 
results were treated only as exploratory. Sensitivity analyses were 
conducted for four additional wear time criteria (see online supple-
mental table appendix 6): Multiple imputation was used to replace 
missing outcome data using baseline outcomes and other explan-
atory covariates (eg, treatment group, age), assuming unobserved 
measurements were missing at random. Given that the proportion 
of patients with missing accelerometry data was <3% out of the 
total number of participants who fulfilled the wear time criteria of 
includable PA data (n=243), no imputation was undertaken for the 
accelerometry related primary and secondary outcome. Using the 
same primary analysis model as described above, between- group 
outcomes were compared in ITT complete case and imputed 
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months. All analyses were conducted by a blinded statistician using 
STATA V.14.2.
Patient and public involvement (PPI)
PPI representatives with diverse clinical conditions and experi-
ence of ERS provided critical feedback on the development and 
usability of the intervention, trial participant- facing documents, 
participant newsletter, on recruitment and trial retention issues, 
and interpretation of the findings and dissemination. Other 
stakeholders involved in the delivery of ERS such as managers 
and practitioners were also consulted in each site.
Process evaluation and economic evaluation
Findings from an embedded process evaluation and economic 
evaluation will be presented elsewhere.
RESULTS
Participant flow through the trial
Figure 1 shows the flow of participants through the trial. The 
reasons for ineligibility at each stage of recruitment are shown in 
online supplemental material appendix 7. Of the 450 participants 
randomised, 232 met our pre set, primary outcome wear time 
threshold (at baseline and 12 months). There was no evidence 
of differences in the demographic characteristics of those 
participants who provided primary outcome data at 12 months 
compared with those that did not provide this follow- up data.
Baseline participant characteristics
Table 2 shows the baseline characteristics of the 450 randomised 
participants as a whole and by trial arm. While in general the two 
arms were well balanced, we noted some small differences within 
categories in respect of education status though numbers in each 
category were small.
Approximately one- third of participants were recruited from 
each of the three sites. As an indication of the level of multi-
morbidity in the sample, 74.2% had two conditions, 30.7% had 
three conditions and 11.8% had four or more conditions.
There was a distinct difference at baseline, for the whole 
sample, between the mean (SD) weekly accelerometer MVPA 
minutes when recorded in ≥10 min bouts (31.0 (83.4)) and 
without bouts (346.0 (251.5)), and the proportion of the whole 
sample who achieved 150 min/week when recorded in ≥10 min 
bouts (4%) and without bouts (80%). These figures compared 
with self- reported data which showed a mean (SD) of 208.8 
(364.0) minutes and 36% achieving 150 min/week.
Intervention engagement
Among intervention participants, 36% did not register and 
log into the e- coachER website, and 36% progressed through 
to at least step 5. The proportion reaching each step is shown 
in online supplemental material appendix 8. The mean (SD) 
number of goal reviews was 2.5 (SD 4.5) with a range of 0–24. 
The 144 participants who registered, logged into e- coachER for 
a mean (SD) and median number of times of 14.1 (16.7) and 
6, respectively, with a range from 1 to 101. Those who regis-
tered spent an estimated mean (SD) and median time engaging 
with the e- coachER web- based support of 48.4 (41.9) min and 
36 min, respectively, with a range of 6–186 min.
Primary outcome
Table 3 shows the primary outcome summary scores at baseline, 
4 and 12 months follow- up. Primary analysis showed a (non- 
significant) weak indicative effect in favour of the intervention 
at 12 months (mean difference 11.8 weekly minutes of MVPA, 
95% CI: −2.1 to 26.0, p=0.10). Given the over dispersion and 
high frequency of zero values in the primary outcome, and the 
poor fit of the primary analysis model, alternative post- hoc regres-
sion models were explored. These included: log transformed 
mixed effects (with a constant added), mixed effect model with 
outliers removed, negative binomial and zero- inflated binomial 
models. These alternative models confirmed the interpretation of 
our primary analysis (see online supplemental material appendix 9 
that also includes model fit graphs). The non- significant between 
Table 1 Summary of secondary outcomes at baseline and 4 and 12 months follow- up and analysis of between group differences at 12 months
Baseline 4- month follow- up 12- month follow- up
Between group difference or 
OR at 12 months*
Mean (95% CI) P value
Control Mean (SD) 
Median (IQR) or 
n/N (%)
Intervention Mean 
(SD) Median (IQR) or 
n/N (%)
Control Mean (SD) 
Median (IQR) or 
n/N (%)
Intervention Mean 
(SD) Median (IQR) 
or n/N (%)
Control Mean (SD) 
Median (IQR) or 
n/N (%)
Intervention Mean 
(SD) n, Median 
(IQR) or n/N (%)
Achievement of at least 
150 min of weekly MVPA 
in ≥10 min bouts†
8/201 (4%) 9/207 (4%) 2/128 (2%) 7/109 (6%) 3/133 (2%) 6/110 (5%) OR: 3.80 (0.16 to 20.92), 0.12
Achievement of at least 
150 min of weekly MVPA†
149/201 (74%) 178/207 (86%) 98/128 (76%) 99/109 (91%) 99/133 (74%) 93/110 (85%) OR: 1.67 (0.82 to 3.42), 0.16














49.3 (−36.3 to 135.0) 0.26
Achievement of at least 
150 min of weekly MVPA 
self- reported
83/220 (37%) 77/220 (48%) 94/183 (51%) 88/166 (53%) 76/170 (45%) 76/154 (49%) OR: 1.23 (0.79 to 1.90), 0.36
Average daily diurnal 
inactivity (hours)†
N=199, 1.7 (1.1) N=205,
1.5 (1.1)
N=125, 1.4 (1.1) N=109,
1.4 (0.9)
N=99, 1.4 (1.0) N=78,
1.5 (1.0)
0.6 (0.5 to 0.7),<0.0001
Average daily sleep 
(hours)†










0.3 (−0.1 to 0.6), 0.11
EQ- 5D- 5L (Devlin values) N=216, 0.74 (0.24) N=215,
0.76 (0.23)
N=162, 0.72 (0.26) N=148,
0.76 (0.25)
N=158, 0.72 (0.26) N=138,
0.73 (0.27)
0.00 (−0.4 to 0.05) 0.89






N=156, 7.1 (4.8) N=139,
6.3 (5.1)
−0.2 (−1.0 to 0.6), 0.44
HADS- A N=217, 8.7 (4.6) N=214,
8.6 (5.1)






−0.5 (−1.2 to 0.2), 0.20
Median (IQR) reported for accelerometry and self- report continuous PA outcomes only.
*Adjusted for baseline MVPA, age, gender, site and minimisation variables.
†Non- bouted accelerometer recorded MVPA adjusted for baseline outcome value, age, gender, site and minimisation variables.
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group difference in primary outcome was consistent across the 
primary and post- hoc models.
CACE analyses for the primary outcome showed a mean differ-
ence of 22.9 weekly minutes of MVPA (95% CI: −3.4 to 47.8, 
p=0.09) in favour of the ERS group. There was no evidence of 
any interactions between stratification variables (site and reason 
for ERS referral), age and gender with the intervention effect for 
the primary outcome at 12 months. Sensitivity analysis showed 
that wear time (ie, days per week, hours per day, etc) did not influ-
ence the findings.
Secondary outcome findings
Table 1 shows the summary descriptive secondary outcomes at 
baseline and 4 and 12 months follow- up. No significant differences 
in the primary analysis for any of the secondary outcomes at 12 
months were seen except for intervention participants spending 
more time in daily diurnal inactivity (sedentary time) at 12 months. 
Secondary analysis models compared imputed secondary outcome 
data sets at 12 months and repeated measures analysis of primary 
and secondary outcomes at both 4 and 12 months were broadly 
consistent with the primary analyses results above.
There was no difference in ERS uptake, between the control 
group, 173/223 (78%) and intervention group, 167/223 (75%).
Serious adverse events (SAEs)
In total, 42 SAEs were reported in 35 participants and were 
all deemed to be either ‘not related’ or ‘unlikely to be related’ 
to the trial. In the control group, there were 26 SAEs among 
21 participants, and in the intervention group there were 16 
SAEs among 14 participants. One SAE was reported as a life- 
threatening event (asthma attack), all other SAEs were hospital-
isations. See online supplemental material appendix 10.
DISCUSSION
Summary of findings
To our knowledge this is the first randomised study to assess the 
effects of adding web- based behavioural support to usual ERS 
support on objectively assessed long- term minutes of MVPA 
among participants with chronic physical and mental health condi-
tions. Augmenting usual ERS using web- based behavioural support 
(e- coachER) provided a (none statistically significant) weak 
indicative effect on objectively assessed minutes of MVPA (when 
recorded in ≥10 min bouts or not) at 12 months among inactive or 
moderately inactive patients. Various sensitivity analyses supported 
these findings. We also found no evidence of benefit in terms of 
ERS uptake and patient- reported outcomes. The extent of engage-
ment with e- coachER was modest, but this factor did not influence 
the findings.
Understanding the findings
Despite our best efforts, we were unable to get follow- up data 
from as many participants as we had planned and this may have 
reduced power to find a statistically significant effect. This has 
been a challenge for other ERS studies as well involving both 
device- based 25 and subjectively26 captured PA; for example, the 
latter study26 followed up only 55.6% of participants at 6 months. 
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Table 2 Baseline characteristics by study group and for the whole sample (N=450 unless stated)
Control group Intervention Both groups
N 226 224 450
Gender—n male (%) 84 (37) 76 (34) 160 (36)












GP PAQ Score—n (%)
  2 (inactive) 144 (63.7%) 149 (66.5%) 293 (65.1%)
  3 (moderately inactive) 82 (36.3%) 75 (33.5%) 157 (34.9%)
Ethnicity—n (%)
  White 195 (86.3%) 179 (79.9%) 374 (83.1%)
  South Asian 11 (4.9 %) 16 (7.2 %) 28 (6.2 %)
  Other 20 (8.8 %) 28 (12.6 %) 48 (10.7 %)
Relationship status—n (%)
  Single, widowed, divorced, or dissolved or surviving civil partnership 124 (54.9%) 112 (50%) 236 (52.4%)
  Married or civil partnership 102 (45.1%) 112 (50%) 214 (47.6%)
Domestic residence status (live with …)—n (%)
  Live alone 59 (26.1%) 48 (21.4%) 107 (23.8%)
  Live with others (eg, parent, child, other family or non- family member 
or partner)
167 (73.9%) 176 (78.6%) 343 (76.2%)
Education status—n (%)
  No qualifications 52 (23.0%) 29 (12.9%) 81 (18.0%)
  GCEs 146 (64.6%) 162 (72.3%) 308 (68.4%)
  A- level 71 (31.4%) 96 (42.9%) 167 (37.1%)
  First degree or above 58 (25.6%) 74 (33%) 132 (29.3%)
  Other 108 (47.8%) 104 (46.4%) 212 (47.1%)
Participant’s perceived possible reason versus main reason for GP referral—n (%)
Prediabetes or diabetes 55 (24.8) versus 24 (11) 57 (26.5) versus 25 (12) 112 (25.6) versus 49 (11)
  Lower limb osteoarthritis 64 (28.3%) versus 27 (12) 45 (20.1) versus 26 (12) 109 (24.2) versus 53 (12)
  Weight loss 182 (80.5) versus 114 (50) 182 (81.3) versus 113 (50) 364 (80.9) versus 227 
(50)
  Low mood 122 (54.0) versus 42 (18) 121 (54.0) versus 42 (19) 243 (54.0) versus 84 (19)
  High blood pressure 79 (35.0) versus 19 (8) 68 (30.4) versus 18 (8) 147 (32.7) versus 37 (8)
Smoking status—n (%)
  Smoker 34 (15.0%) 32 (14.3%) 66 (14.7%)
  Ex- smoker 90 (39.8%) 89 (39.7%) 179 (39.8%)
  Never smoked 102 (45.1%) 103 (46.0%) 205 (45.6%)
IT literacy/confidence level—n (%)1
  Low 36 (16%) 35 (16%) 72 (16%)
  High 190 (84%) 189 (84%) 379 (84%)
Site—n (%)
  Birmingham 78 (34%) 76 (34%) 154 (34%)
  Glasgow 69 (31%) 72 (32%) 141 (31%)
  Plymouth 79 (35%) 76 (34%) 155 (35%)
Weekly MVPA minutes (in ≥10 min bouts)—n, mean (SD)*Median (IQR) 201, 30.2 (105.8)
201, 0 (0, 23.3)
207, 31.8 (53.7)
207, 7.5 (0, 41.1)
408, 31.0 (83.4)
408, 0 (0–30.3)






n (%) achieving 150 min (in ≥10 min bouts)* 8/201 (4%) 9/207 (4%) 17/408 (4%)
n (%) achieving 150 min (no bouts)* 149/201 (74%) 178/207 (86%) 327/408 (80%)






N (%) achieving 150 weekly minutes of self- reported MVPA 83/220 (37%) 77/220 (35%) 160/440 (36%)
EQ- 5D- 5L (Devlin)—n, mean (SD) 216, 0.74 (0.24) 215 0.76 (0.23) 431, 0.75 (0.24)
HADS- D—n, mean (SD) 217, 7.6 (4.5) 214, 7.4 (4.7) 431, 7.5 (4.6)
HADS- A—n, mean (SD) 217, 8.7 (4.6) 214, 8.6 (5.1) 431, 8.6 (4.9)
On a 10 point Likert scale, scores of 1-5 indicated a low literacy level and scores of 6-10 a high literacy level.
*Accelerometer recorded.
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The e- coachER study was initially powered to detect differences 
in numbers achieving 150 min of MVPA based on our systematic 
review.9 Due to early recruitment issues, the sample size was recal-
culated as reported, with the primary outcome based on ≥10 min 
bouts. The scant available data from device- based assessed PA in 
comparable trials made the power calculation somewhat uncertain, 
and we also need to know more about what is a clinically signifi-
cant change in device- based assessed MVPA to justify sample sizes.
Our prespecified analysis plan, involving a measure of MVPA 
in bouts of ≥10 min, meant that a larger proportion of the sample 
than expected recorded zero minutes. This required us to explore 
a number of analysis models for the primary analysis, none of 
which were ideal but did provide a consistent conclusion. Given 
that other studies have reported findings using a different acceler-
ometer wear time (eg, Harris et al reported MVPA minutes from 
‘at least 1 day’ to estimate weekly activity22 we also considered our 
data with a range of wear time criteria, and again the findings were 
consistent.
The primary focus was on differences in MVPA minutes at 12 
months, but both groups showed an increase at 4 months. Our 
aim was to increase uptake and long- term change in MVPA, given 
concerns that ERS only foster short- term change,9 but providing 
the e- coachER intervention at the same time as what was some-
what effective ERS support may have limited the perceived need 
for e- coachER engagement. Also, digital support interventions are 
renowned for having relatively short- term engagement and effects, 
so it may be that greater digital support is needed after 4 months 
(the typical duration of ERS).
In line with guidelines for ERS research,27 we tried to make the 
intervention as accessible as possible to participants from a wide 
range of socioeconomic backgrounds, which we achieved to some 
extent, but with an increasing array of devices for self- monitoring 
and setting goals for PA, and it may be that many participants in 
both arms of our sample were independently accessing these, which 
thereby negated any benefits from the e- coachER intervention.
Other considerations
We found a large discrepancy between the proportion of the 
sample who achieved 150 min of accelerometer recorded MVPA 
when assessed in ≥10 min bouts (4%) or not (80%), and by self- 
report (36%) at baseline, despite selecting sedentary or inactive 
participants for the trial. This finding also aligns with recently 
reported data from the USA, which identified a range of 3.4%–
95.6% of people achieving 150 min of MVPA depending on how 
the accelerometer data were processed.28 This is important given 
the recent removal of the ‘≥10 min bouts’ in UK and international 
guidelines.29 30 It has been suggested that data collected using accel-
erometers is incompatible with guidelines of 150 min of MVPA per 
week and a value of about 1000 unbouted minutes of MVPA would 
need to be recommended for public health benefits.31 Our sample 
at baseline recorded only 346 min of unbouted weekly MVPA, 
which highlights the uniqueness of the study involving attempts to 
support change in such a low active sample, who potentially have 
the greatest to gain in terms of health from increases in MVPA.
A final consideration is that there was a small indication of 
imbalance in educational status between the groups at baseline, 
with a greater proportion of those with no qualification, and 
a slightly smaller proportion with higher qualifications, in the 
control group. However, given the relative small numbers of 
those in the respective categories for educational status, the fact 
that we had not specified inclusion of this variable in our statis-
tical analysis plan for the primary analysis, and the absence of 
between group differences in IT confidence, we chose not to 
further explore any confounding effects of educational status.
Further research
The focus on accumulating ≥10 min bouts for health benefit has 
now been dropped in global guidelines but in presenting both 
bouted and unbouted total MVPA the present study will provide 
Table 3 Summary of primary outcome data at baseline and 4 and 12 months follow- up and analysis of between group differences in total weekly 
minutes (recorded in bouts and no bouts) at 12 months
Baseline 4- month follow- up 12- month follow- up
Between group 
difference at 12 months*





(n=207) Mean (SD) 
Median (IQR)
Control
(n=128) Mean (SD) 
Median (IQR)
Intervention
(n=109) Mean (SD) 
Median (IQR)
Control
(n=133) Mean (SD) 
Median (IQR)
Intervention
(n=110) Mean (SD), 
Median (IQR)
Total weekly minutes of 













11.8 (−2.1 to 26.0), 0.10















13.7 (−26.8 to 54.2), 0.51
Data from participants included as per primary analysis with 232 participants providing data at baseline and 12 months, and of these, from the 172 who provided data at 4 months.
*Adjusted for baseline MVPA, age, gender, site and minimisation variables.
†Unbouted minutes.
MVPA, moderate- to- vigorous physical activity.
What are the key findings?
 ► With lower than desired follow- up rates, we found no 
significant effect of augmenting usual primary care exercise 
referral schemes with the e- coachER intervention on 
12 month objectively assessed physical activity (PA), among 
low active participants with chronic conditions.
 ► Engagement in the web- based support was modest despite 
being based on contemporary behaviour change theories, 
other effective interventions and good public and patient and 
stakeholder involvement in the development.
How might it impact on clinical practice in the future?
 ► The study was conducted pre COVID 19 and the need to 
find effective digital support for patients to facilitate greater 
uptake of exercise referral scheme (ERS) and sustained 
change in PA for the management of chronic conditions has 
only increased.
 ► Local digital solutions could be developed in primary care to 
better manage and monitor the progress of patients in an 
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valuable device- based information to inform future related 
research. Changes in international guidelines have removed 
the importance of completing PA in ≥10 min bouts, which in 
turn changes the basis for powering studies since a much greater 
proportion of the population are likely to meet the new unbouted 
target of 150 min of MVPA per week.
Practical implications
There remain digital opportunities to provide support for patients 
to facilitate greater uptake of ERS and sustained change in PA for 
the management of chronic conditions. Bespoke software, drawing 
on some of the concepts and content in e- coachER could be used to 
ensure better links between the referee in primary care and patient. 
There can be confusion about what the ERS involves, compounded 
sometimes by delayed starting. Beyond the formal ERS, digital 
systems could be implemented to maintain long- term MVPA.
CONCLUSION
Augmenting ERS referrals with web- based behavioural support 
had only a weak, non- significant indicative effect on acceler-
ometer recorded MVPA at 12 months, and no effect on ERS 
engagement. Overall, there was only modest engagement in the 
e- coachER web- based support, but degree of engagement did 
not influence the overall findings.
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